Additionally, we were able to identify subgroups of BC patients with marginal statistically significant association between higher CK1ε expression and an increase in DFS, which are those having an age ≥ median, Ki67 ≥ median, or wild-type p53 or those without triple-negative breast cancer. This evidence concerns the gene TP53 and triple-negative breast carcinoma.